Novavax, Inc.NVAXNASDAQ
Loading
EBITDA Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

EBITDA as a percentage of revenue

Latest
43.82%
↑ 107% vs avg
Percentile
P100
Near historical high
Streak
2 yr
Consecutive growthExpanding
Average
-600.57%
Historical baseline
PeriodValueYoY Change
TTM43.82%+376.7%
2024-15.84%+81.9%
2023-87.60%-131.6%
2022-37.82%+95.6%
2021-850.66%+52.2%
2020-1778.76%-193.0%
2019-607.02%-27.7%
2018-475.32%+7.3%
2017-512.83%+69.5%
2016-1683.68%-